Drug sensitivity spectra in Fanconi anemia lymphoblastoid cell lines of defined complementation groups.
Fanconi anemia (FA) is one of several genetic diseases with characteristic cellular hypersensitivity to DNA crosslinking agents which suggest that FA proteins may function as part of DNA repair processes. At the clinical level, FA is characterized by bone marrow failure that affects children at an early age. The clinical phenotype is heterogeneous and includes various congenital malformations as well as cancer predisposition. FA patients are distributed into eight complementation groups suggesting a complex molecular pathway. Three of the eight possible FA genes have been cloned, although their function(s) have not been identified. FA cells are highly sensitive to DNA crosslinking agents (mitomycin C (MMC) and diepoxybutane), with some variability between cell lines. Sensitivity to monofunctional alkylating agents has been reported in some cases, although these studies were performed with genetically unclassified FA cells. To further analyse and characterize the newly identified FA complementation groups, we tested their sensitivity to UV radiation, monofunctional and bifunctional alkylating agents and to the X-ray mimetic drug bleomycin. We found that FA complementation groups D to H show increased sensitivity to the X-ray mimetic drug bleomycin. Furthermore, the single known FA-H cell line shows increased sensitivity to ethylethane sulfonate (EMS), methylmethane sulfonate (MMS) in addition to the characteristic sensitivity to crosslinking agents, suggesting a broader spectrum of drug sensitivities in FA cells.
Carreau
M
M
Program in Genetics and Genomic Biology, Hospital for Sick Children, Toronto, ON, Canada.
Alon
N
N
Bosnoyan-Collins
L
L
Joenje
H
H
Buchwald
M
M
D018906:Antineoplastic Agents, Alkylating / Q000494:pharmacology*; D002460:Cell Line; D005199:Fanconi Anemia / Q000473:pathology*; D005816:Genetic Complementation Test; D006801:Humans; D009153:Mutagens / Q000494:pharmacology*
D018906:Antineoplastic Agents, Alkylating; D009153:Mutagens